Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial

Vu Dinh Thiem, Dang Duc Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, Jose Mateus, Juan Manuel Carreño, Rama Raghunandan, Nguyen Mai Huong, Laina D Mercer, Jorge Flores, E Alexandar Escarrega, Ariel Raskin, Duong Huu Thai, Le Van Be, Alessandro Sette, Bruce L Innis, Florian Krammer, Daniela Weiskopf
doi: https://doi.org/10.1101/2023.11.30.23299208

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
Posted December 01, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial
Vu Dinh Thiem, Dang Duc Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, Jose Mateus, Juan Manuel Carreño, Rama Raghunandan, Nguyen Mai Huong, Laina D Mercer, Jorge Flores, E Alexandar Escarrega, Ariel Raskin, Duong Huu Thai, Le Van Be, Alessandro Sette, Bruce L Innis, Florian Krammer, Daniela Weiskopf
medRxiv 2023.11.30.23299208; doi: https://doi.org/10.1101/2023.11.30.23299208
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area